U.S. market Closed. Opens in 17 hours 19 minutes

PAVS | Paranovus Entertainment Technology Ltd. Stock Overview

(Stock Exchange: NASDAQ)
Day's Range 0.9600 - 0.9605
52 Week Range 0.3200 - 3.10
Beta N/A
Implied Volatility N/A
IV Rank N/A
Day's Volume 2,460
Average Volume 154,657
Shares Outstanding 66,724,700
Market Cap 64,055,712
Sector Consumer Defensive
Industry Packaged Foods
IPO Date 2019-10-25
Valuation
Profitability
Growth
Health
P/E Ratio 1.28
Forward P/E Ratio N/A
EPS 0.75
1YR Price Target N/A
Dividend Yield N/A
Dividend Per Share N/A
Dividend ExDate N/A
Dividend PayDate N/A
Employees 11
Country China
Website PAVS
Paranovus Entertainment Technology Ltd. engages in the research, development, manufacture, and sale of nutraceutical and dietary supplement products in the People's Republic of China and internationally. The company's product category includes lucidum spore powders, cordyceps mycelia, Ejiao products, American ginseng products, other traditional Chinese herbal and animal extracts, vitamins, minerals, and amino acids. It also offers product marketing and e-commerce agency operation services under the Happy Buy platform to small and middle size businesses; and e-commerce solutions, internet information, and advertising services to the online stores or manufactures. In addition, the company provides secure transaction environment, automobile procurement, and financial services for automobile manufacturers under the Taochejun automobile sales platform. It sells its products through distributors, large-scale chain drugstores, malls, and supermarkets under the Happiness brand. The company was formerly known as Happiness Development Group Limited and changed its name to Paranovus Entertainment Technology Ltd. in March 2023. Paranovus Entertainment Technology Ltd. was founded in 2004 and is headquartered in Nanping, the People's Republic of China.
PAVS's peers: BTTR, NCRA
*Chart delayed
Analyzing fundamentals for PAVS we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is weak. For more detailed analysis please see PAVS Fundamentals page.

Watching at PAVS technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on PAVS Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙